We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr Wins Approvals for Generic Zithromax, Kytril
Barr Wins Approvals for Generic Zithromax, Kytril
February 6, 2007
Barr Pharmaceuticals and its subsidiary Pliva have won final FDA approval to manufacture and market injectable azithromycin, a generic version of Pfizer's Zithromax.